SCHEMBL6204523

SCHEMBL6204523

CCCCC(C(=O)OCC)c1ccc(C)cc1

nearest known ligand 0.49

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
MAPK1 P28482 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
PTGES O14684 1/20 0.41
ALOX5 P09917 1/20 0.41
PPARG P37231 1/20 0.41
PPARA Q07869 1/20 0.41
TDP1 Q9NUW8 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
HRH3 Q9Y5N1 1/20 0.39
AURKA O14965 1/20 0.38
NTRK1 P04629 1/20 0.38
MAPT P10636 1/20 0.38
RECQL P46063 1/20 0.38
ALDH1A1 P00352 2/20 0.38
POLB P06746 1/20 0.38
CA2 P00918 1/20 0.38
CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28920116 0.94 MEN1 (0.47) MEN1KMT2AMAPK1SMN1; SMN2TDP1
SCHEMBL13980904 0.90 MEN1 (0.47) MEN1KMT2ASMN1; SMN2ALOX5TDP1
SCHEMBL10410232 0.89 ESR1 (0.46) MEN1KMT2AMAPK1SMN1; SMN2TDP1
SCHEMBL1767974 0.87 LMNA (0.47) MEN1KMT2AMAPK1SMN1; SMN2TDP1
SCHEMBL4206097 0.87 MMP8 (0.50) MEN1KMT2ASMN1; SMN2TDP1ALDH1A1
Hydrochloric Acid SCHEMBL12273789 0.86 LMNA (0.46) MEN1KMT2AMAPK1SMN1; SMN2TDP1
SCHEMBL16280745 0.84 MAPT (0.41) MEN1KMT2AMAPK1SMN1; SMN2TDP1
SCHEMBL6207003 0.83 KMT2A (0.43) MEN1KMT2ATDP1ALDH1A1POLB
SCHEMBL10896682 0.83 POLB (0.49) MEN1KMT2AMAPK1SMN1; SMN2PTGES
SCHEMBL5699336 0.83 ESR1 (0.44) MAPK1SMN1; SMN2ALDH1A1CA2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1564200-A1 Ketone compounds and compositions for cholesterol management and related uses Esperion Therapeutics Inc. (US) 2005-08-17 EP disclosed
CN-1061410-A Substituted azole, its preparation method comprises the preparation and the application thereof of substituted azole HOECHST AG (DE) 1992-05-27 CN disclosed